<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 04 Jun 2026 04:41:20 -0400--><rss version="2.0">
    <channel>
        <title>Atara Biotherapeutics (ATRA) SEC Filings</title>
        <link>https://investors.atarabio.com/sec-filings/all-sec-filings/rss</link>
        <description>Atara Biotherapeutics (ATRA) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/atarabio/files/theme/images/logo-sm.png</url>
                <title>Atara Biotherapeutics Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002571/0000905148-26-002571.pdf</link>
                <pubDate>Wed, 20 May 26 17:27:32 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002571/0000905148-26-002571.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002570/0000905148-26-002570.pdf</link>
                <pubDate>Wed, 20 May 26 17:26:35 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002570/0000905148-26-002570.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002506/0000905148-26-002506.pdf</link>
                <pubDate>Mon, 18 May 26 16:45:52 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002506/0000905148-26-002506.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002507/0000905148-26-002507.pdf</link>
                <pubDate>Mon, 18 May 26 16:45:45 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000905148-26-002507/0000905148-26-002507.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership]]></title>
                <description><![CDATA[SCHEDULE 13D/A]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001104659-26-061506/0001104659-26-061506.pdf</link>
                <pubDate>Thu, 14 May 26 21:00:51 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001104659-26-061506/0001104659-26-061506.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[2 Related Documents: SCHEDULE 13G, EX-99.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000919574-26-002914/0000919574-26-002914.pdf</link>
                <pubDate>Wed, 13 May 26 09:06:41 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000919574-26-002914/0000919574-26-002914.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[424B5 - Prospectus [Rule 424(b)(5)]]]></title>
                <description><![CDATA[424B5]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-219518/0001193125-26-219518.pdf</link>
                <pubDate>Tue, 12 May 26 16:32:04 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-219518/0001193125-26-219518.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-219482/0001193125-26-219482.pdf</link>
                <pubDate>Tue, 12 May 26 16:27:28 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-219482/0001193125-26-219482.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-219420/0001193125-26-219420.pdf</link>
                <pubDate>Tue, 12 May 26 16:21:32 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-219420/0001193125-26-219420.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership]]></title>
                <description><![CDATA[SCHEDULE 13D/A]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-217389/0001193125-26-217389.pdf</link>
                <pubDate>Mon, 11 May 26 18:49:34 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-217389/0001193125-26-217389.pdf</guid>
                                                                            </item>
            </channel>
</rss>